ISSN: 2332-0877
Journal of Infectious Diseases & Therapy
Make the best use of Scientific Research and information from our 700+ peer reviewed, Open Access Journals that operates with the help of 50,000+ Editorial Board Members and esteemed reviewers and 1000+ Scientific associations in Medical, Clinical, Pharmaceutical, Engineering, Technology and Management Fields.
 
Meet Inspiring Speakers and Experts at our 3000+ Global Conferenceseries Events with over 600+ Conferences, 1200+ Symposiums and 1200+ Workshops on
Medical, Pharma, Engineering, Science, Technology and Business
 
Review Article
Open Access
 

EV71, A Virus with Complicated Pathogenesis in the CNS

Min Feng and Qihan Li*
Institute of Medical Biology, Chinese Academy of Medicine Sciences & Peking Union Medical College, Kunming, 650118, China
Corresponding Author : Qihan Li
Institute of Medical Biology Chinese Academy of Medicine Sciences and
Peking Union Medical College, China
Tel: 86-871-68335905
Fax: 86-871-68334483
E-mail: imbcams.lq@gmail.com
Received June 02, 2014; Accepted July 15, 2014; Published July 20, 2014
Citation: Feng M, Li Q (2014) EV71, A Virus with Complicated Pathogenesis in the CNS. J Infect Dis Ther 2:153. doi:10.4172/2332-0877.1000153
Copyright: © 2014 Feng M, et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Related article at
DownloadPubmed DownloadScholar Google
Visit for more related articles at Journal of Infectious Diseases & Therapy
 

Abstract

Fatal cases of hand, foot, and mouth disease (HFMD) caused by enterovirus 71 (EV71) infection are characterized by inflammatory damage to the central nervous system (CNS) with slight degeneration of nerve cells. Here, we review several studies that identify potential host factors and possible mechanisms of neuropathogenesis of EV71 infection.

Abstract
Fatal cases of hand, foot, and mouth disease (HFMD) caused by enterovirus 71 (EV71) infection are characterized by inflammatory damage to the central nervous system (CNS) with slight degeneration of nerve cells. Here, we review several studies that identify potential host factors and possible mechanisms of neuropathogenesis of EV71 infection.
Keywords
Enterovirus 71 (EV71); Neuropathogenesis; Central Nervous System (CNS); Astrocytes
Introduction
Enterovirus 71 (EV71) is the primary neurological threat responsible for fatalities in outbreaks of hand, foot, and mouth disease (HFMD) [1-5]. Patients with HFMD are defined as severe cases if they develop any neurological or/and cardiopulmonary complications accompanied by fever, skin rashes or on the hands, feet, and mouth [5]. Aseptic meningitis, brainstem encephalitis, and encephalomyelitis are the cardinal signs of EV71 infection of the CNS [6,7]. With the increased severity of disease, the damage to the CNS leads to neurogenic pulmonary edema, functional cardiopulmonary failure, and, consequently, the high rate of mortality [8,9]. Therefore, it is critical to understand the pathological mechanisms behind the severe clinical manifestations, which has recently drawn increasing attention from researchers.
The faeco-oral route is the predominant mode of EV71 transmission. EV71 invades the CNS through either the disruption of the blood-brain barrier or retrograde spinal neural transport. Generally, animal studies [10] and assessment of the distribution of the virus in fatal human cases [11] indicate that the latter may be the major route of transmission of EV71.
Central Nervous System (CNS) by EV71
With infection of the CNS by EV71, viral antigen can be detected by staining in CNS tissues in a variety of cell types, including neurons, microglia, and astrocytes [12]. Viral entry into the CNS usually leads to a strong inflammatory response. The severity of inflammation is high in the spinal cord and the medulla oblongata and lower in the hypothalamus, thalamus and part of the cerebrum [11,13,14]. The concomitant histopathological manifestations in the CNS are typically detected as confined vascular inflammatory cell infiltration, variable edema, glial cell proliferation and glial nodule formation [15,16]. Correspondingly, the levels of inflammatory cytokines in the cerebral spinal fluid (CSF) are elevated [17]. Interestingly, unlike other neurotropic viruses (such as poliovirus) with distinctive necrosis and destruction of the majority of neural cells [18], EV71 only induces slight neurodegeneration, rather than the widespread necrosis of neural cells in the CNS that is frequently associated with these pathological changes [19,20]. This suggests that the observed CNS damage by EV71 might be induced by unidentified inflammatory responses distinct from other neurotropic viruses.
Here, we try to raise some questions regarding the peculiar inflammatory response observed during the EV71 infection in the CNS. What are the possible mechanisms of neuropathogenesis of EV71 infection? As demonstrated by our previous studies of the pathogenic mechanisms of EV71 infection in the CNS, the viral load in the CNS peaks during the infectious process in neonatal rhesus monkey models [21]. Moreover, the peak of viral replication in the CNS has been shown to be closely related to the substantial inflammatory reaction in the CNS tissues [21,22]. Additionally, K. T. Wong et al also found that the regions in which EV71 associated inflammation occurred partially correlated to the regions where viral RNA and antigens were detected [11]. These findings indicate an association between EV71 replications in the CNS tissue and the induction of an inflammatory response.
Multiple studies have found that several types of immune cells are involved in EV71 infection. For example, the interaction between neutrophils (or leukocytes) and vascular smooth muscle cells may contribute to inflammation and immune response during EV71 infection [23]. Human dendritic cells might be infected by the EV71 virus, triggering the release of proinflammatory factors by the dendritic cells, such as IL-6, IL-12 and TNF-α [24]. Additionally, EV71 infection activates NF-kb and leads to the production of many proinflammatory factors. This study also showed that up-regulation of COX-2 is associated with the release of PGE2 from EV71-infected SK-N-SH cells in vitro [25]. These findings suggest that these signaling pathways may also contribute to EV71 infection.
Because immune cells are a minority cell type in the CNS, we moved our focus to other cell populations—neurons and glia in the CNS. As previously described, neuronal degeneration and necrosis were slight and observed limitedly in the spinal cord as well as in a small section of upper motor neurons [10,12,26,27]. Based on these results, researchers also aimed to study the other cell populations in the CNS, such as glia. Previous studies have shown that the microglia and astrocytes, the most abundant cells in the CNS, act as important functional cells [28]. Current interest in these cells was based on not only their important neurobiological function of selectively regulating neural cell activities and synaptic transmission, [29,30] but also on their phagocytic capability and their ability to express multiple immune factors similar to other immune cells [31-33]. To date, the data concerning the role of microglia and astrocytes in EV71 infection are limited and primarily from autopsy studies, in which immunohistochemical analysis demonstrated that EV71 antigen was observed in microglia and astrocytes in the CNS of fatal human cases [34,35]. In addition, two in vitro study using the established human astrocytoma cell lines, to the extent demonstrated that astrocytes were permissive to infection by EV71 [36,37]. However, astrocytes are a focus of our study of EV71 infection and pathogenesis in the CNS. Recent work (unpublished data) in our lab identified astrocytes as the primary cell type involved in EV71 infection in the CNS. This work was done using in vivo experiments performed in neonatal rhesus monkey and suckling mouse models and in vitro experiments using a cellular model. Strikingly, astrocytes have the capacity to substantially modulate neuronal function via the canonical expression of proinflammatory cytokines during EV71 infection. This subsequently stimulates the neuronal secretion of adrenaline, an excitatory neurotransmitter that is considered a likely cause of the pathophysiological events in fatal HFMD cases, which are characterized by the development of neurogenic pulmonary edema and cardiopulmonary dysfunction.
In addition, the interaction between virus and receptors is considered to be important in the early steps of viral infection. It is usually a complex multistep process that sequentially involves the recognition of one receptor or the simultaneous recognition of multiple cell-surface receptors during virus attachment followed by entry into host cells [38]. To date, SCARB-2 [39], PSGL-1 [40] and DC-SIGN [24] have been identified as the receptors for EV71 infection, but they may be involved in different steps during the EV71 infection process. A recent autopsy study revealed that the expression of SCARB-2 and EV71 antigen colocalize in the human CNS, whereas SCARB-2 is poorly expressed in the mouse CNS [12]. Another recent study using transgenic mice expressing the human EV71 receptor, SCARB-2, found that the mice are more susceptible to EV71 infection than the wild type mice, confirming that SCARB-2 is important for EV71 infection in vivo [41]. However, our current study showed that specific antibodies against the EV71 receptor molecules, such as SCARB-2, PSGL-1 and DC-SIGN, frequently failed to inhibit viral replication in monkey astrocytes in vitro. These results suggested that EV71 infection of astrocytes may be directly attributed to the phagocytosis of the viruses based on the basic phagocytic function of astrocytes.
Conclusion
In summary, although studies have determined several potential factors involved in EV71 infection in the CNS, many questions remain unanswered. Which inflammatory mediators and cell populations protect adults from damage to the CNS during EV71 infection? Do astrocytes in the CNS phagocytose and kill destroy the EV71 virus? EV71 infection usually causes fatal cases in infants or young children. We should pay attention to patients in this specific age range in future work. These important questions merit further investigation, and the answers may provide novel therapeutic or prophylactic targets to cure this infectious disease.
Acknowledgment
This project was supported by the National Basic Research Program (2011CB504903), National High-Tech R&D Program (2012AA02A404), National Natural Sciences Foundation of China (81171573 and 31370192). We thank Dr. Junjie Mei for his editorial help. All named authors meet the ICMJE criteria for authorship for this manuscript, and take responsibility for the integrity of the work as a whole.
Conflict of Interest
Min Feng declares no conflict of interest. Qihan Li declares no conflict of interest.
References









































References










































Select your language of interest to view the total content in your interested language
 
Share This Article
   
 
   
 
Relevant Topics
Disc Adaptive Immunity
Disc Advanced Therapies
Disc Allergy Immunology
Disc Anatomical Pathology
Disc Anthrax
Disc Automated Tissue Image Analysis
Disc Bacteraemia
Disc Bacteria Induced Neuropathies
Disc Bacterial Ecology
Disc Bacterial Genomics
Disc Bacterial Infections
Disc Bacterial Toxin
Disc Bacteriology
Disc Brain Infection
Disc Cellular Immunology
Disc Cellular Pathology
Disc Chemical Pathology
Disc Chicken Pox
Disc Clinical Immunology
Disc Clinical Pathology
Disc Colon Infection
Disc Conjunctivitis
Disc Cooperative Human Tissue Network
Disc Diagnostic Immunology
Disc Escherichia coli
Disc Evolutionary Immunology
Disc Experimental Pathology
Disc Fungal Infection
Disc HIV and AIDS Research
Disc Hematopathology
Disc Herpes Virus
Disc Host-Pathogen Interactions
Disc Human Papilloma Virus
Disc Infection
Disc Infection in Blood
Disc Infections Prevention
Disc Infectious Disease in Children
Disc Infectious Diseases in Children
Disc Inflammatory Disorders
Disc Influenza
Disc Intestinal Parasites
Disc Leprosy
Disc Listeriosis
Disc Lyme Disease
Disc Neuro-HIV and Bacterial Infection
Disc Neuro-Infections Induced Autoimmune Disorders
Disc Neurocystercercosis
Disc Neurocysticercosis
Disc Neuroepidemiology
Disc Neuroinfectious Agents
Disc Neuroinflammatory Disorders
Disc Neuropathology
Disc Neurosyphilis
Disc Neurovirology
Disc Ocular Immunology and inflammation
Disc Parasitic Infection
Disc Parasitic Worms
Disc Parasitology
Disc Phytopathology
Disc Rare Infectious Disease
Disc Renal Pathology
Disc Respiratory Tract Infections
Disc Rickettsioses
Disc Salmonella
Disc Salmonellosis
Disc T Cell Lymphomatic Virus
Disc Toxoplasmosis
Disc Translational Immunology
Disc Transplantation Immunology
Disc Treatment for Infectious Diseases
Disc Tumor Immunology
Disc Vaccine Immunology
Disc Viral Encephalitis
Disc Viral Immunology
Disc Viral Infection
Disc Yeast Infection
Disc Zoonotic Bacterial Diseases
 
Recommended Journals
Disc Clinical Infectious Disease Journal
Disc Immunology Journal
Disc Pathology Journal
Disc Bacteriology Journal
Disc Neuroinfectious Disease Journal
  View More»
 
Recommended Conferences
Disc 5th International Conference and Exhibition on Occupational Health & Safety
June 09-10, 2016, Dallas, USA
Disc 4th International Conference on Epidemiology and Public Health  
October 03-05, 2016 London, United Kingdom
Disc 7th World Congress and Expo on Applied Microbiology
November 10-12, 2016 Istanbul, Turkey
Disc 7th World Congress on Virology
November 21-23, 2016 Baltimore, USA
Disc 10th International Conference on Nursing and Healthcare
December 05-07, 2016 Dallas, USA
View More»
 
Article Tools
Disc Export citation
Disc Share/Blog this article
 
Article usage
  Total views: 11267
  [From(publication date):
October-2014 - May 30, 2016]
  Breakdown by view type
  HTML page views : 7540
  PDF downloads :3727
 
 

Post your comment

captcha   Reload  Can't read the image? click here to refresh

 
OMICS International Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
 
 
OMICS International Conferences 2016-17
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings
 
 

Contact Us

Agri, Food, Aqua and Veterinary Science Journals

Dr. Krish

agrifoodaquavet@omicsinc.com

1-702-714-7001 Extn: 9040

Clinical and Biochemistry Journals

Datta A

clinical_biochem@omicsinc.com

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

business@omicsinc.com

1-702-714-7001Extn: 9042

Chemical Engineering and Chemistry Journals

Gabriel Shaw

chemicaleng_chemistry@omicsinc.com

1-702-714-7001 Extn: 9040

Earth & Environmental Sciences

Katie Wilson

environmentalsci@omicsinc.com

1-702-714-7001Extn: 9042

Engineering Journals

James Franklin

engineering@omicsinc.com

1-702-714-7001Extn: 9042

General Science and Health care Journals

Andrea Jason

generalsci_healthcare@omicsinc.com

1-702-714-7001Extn: 9043

Genetics and Molecular Biology Journals

Anna Melissa

genetics_molbio@omicsinc.com

1-702-714-7001 Extn: 9006

Immunology & Microbiology Journals

David Gorantl

immuno_microbio@omicsinc.com

1-702-714-7001Extn: 9014

Informatics Journals

Stephanie Skinner

omics@omicsinc.com

1-702-714-7001Extn: 9039

Material Sciences Journals

Rachle Green

materialsci@omicsinc.com

1-702-714-7001Extn: 9039

Mathematics and Physics Journals

Jim Willison

mathematics_physics@omicsinc.com

1-702-714-7001 Extn: 9042

Medical Journals

Nimmi Anna

medical@omicsinc.com

1-702-714-7001 Extn: 9038

Neuroscience & Psychology Journals

Nathan T

neuro_psychology@omicsinc.com

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

John Behannon

pharma@omicsinc.com

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

social_politicalsci@omicsinc.com

1-702-714-7001 Extn: 9042

 
© 2008-2016 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version